Parameter | Non-AKI group (n = 30) | High-risk group (n = 30) | AKI group (n = 11) | n’ | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Colic (n = 10) | n’ | NSAIDs (n = 10) | n’ | Gentamicin (n = 10) | n’ | All | n’ | |||||
Me (Q1–Q3) | Me (Q1–Q3) |  | Me (Q1–Q3) |  | Me (Q1–Q3) |  | Me (Q1–Q3) |  | Me (Q1–Q3) | |||
Serum | Urea (3.3–6.7 mmol/L) | 5.7 (4.6–6.3) | 5.9 (5.4–6.4) | 0 | 5.4 (5.2–5.7) | 0 | 6.2 (5.6–6.4) | 0 | 5.7 (5.3–6.4) | 0 | 12.3ac (10.6–23.9) | 11 |
Creatinine (71–159 µmol/L) | 120.0 (93.0–137.0) | 125.1 (105.6–144.5) | 1 | 133.5 (124.0–155.0) | 1 | 124.9 (99.3–129.7) | 0 | 129 (103.8–136.9) | 2 | 305.0ac (228.0–440.2) | 11 | |
Urine | pH (7.5–8.5) | 8.0 (8.0–8.4) | 7.75 (7.5–8.07) | 2 | 8.5 (7.96–8.5) | 2 | 8.0 (7.9–8.5) | 0 | 8.0 (7.8–8.5) | 4 | 6.0ac (5.45–7.95) | 5 |
SG (1.02–1.04 g/L) | 1.031 (1.021–1.042) | 1.031 (1.021–1.039) | 0 | 1.03 (1.019–1.034) | 1 | 1.035 (1.031–1.036) | 0 | 1.033 (1.02–1.036) | 1 | 1.013 (1.011–1.022) | 4 | |
Protein (< 1 g/L) | 0.07 (0.03–0.1) | 0.3b (0.23–1.16) | 3 | 0.21b (0.14–0.24) | 1 | 0.14c (0.09–0.16) | 0 | 0.21b (0.13–0.32) | 4 | 0.69a (0.38–1.24) | 5 | |
UPCR (< 0.5) | 0.023 (0.014–0.04) | 0.11b (0.08–0.63) | 2 | 0.08b (0.1–0.16) | 0 | 0.084c (0.048–0.095) | 0 | 0.1b (0.08–0.16) | 2 | 0.65a (0.35–3.1) | 5 | |
GGT:Crea (< 5 IU/mmol) | 1.07 (0.74–1.52) | 1.9b (1.5–2.2) | 0 | 1.35 (1.25–1.56) | 0 | 1.31 (1.12–1.54) | 0 | 1.44 (1.22–1.97) | 0 | 4.55ac (1.62–7.19) | 5 | |
FENa (< 1%) | 0.08 (0.06–0.12) | 0.14 (0.13–0.15) | 0 | 0.1c (0.06–0.16) | 1 | 0.12c (0.05–0.23) | 0 | 0.13 (0.07–0.17) | 1 | 1.95ac (0.44–5.8) | 6 |